All Stories

  1. Genome-wide association study identifies genetic factors that modify age at onset in Machado-Joseph disease
  2. Founder Effects of Spinocerebellar Ataxias in the American Continents and the Caribbean
  3. Free carnitine and branched chain amino acids are not good biomarkers in Huntington’s disease
  4. Correction to: Genetic Analysis of Hereditary Ataxias in Peru Identifies SCA10 Families with Incomplete Penetrance
  5. Genetic Analysis of Hereditary Ataxias in Peru Identifies SCA10 Families with Incomplete Penetrance
  6. Variation in DNA Repair System Gene as an Additional Modifier of Age at Onset in Spinocerebellar Ataxia Type 3/Machado–Joseph Disease
  7. ATXN10 Microsatellite Distribution in a Peruvian Amerindian Population
  8. Population medical genetics: translating science to the community
  9. A case series of hereditary cerebellar ataxias in a highly consanguineous population from Northeast Brazil
  10. Niemann-Pick Disease Type C: Mutation Spectrum and Novel Sequence Variations in the Human NPC1 Gene
  11. Ophthalmological and Neurologic Manifestations in Pre-clinical and Clinical Phases of Spinocerebellar Ataxia Type 7
  12. Sensitivity, advantages, limitations, and clinical utility of targeted next-generation sequencing panels for the diagnosis of selected lysosomal storage disorders
  13. State biomarkers for Machado Joseph disease: Validation, feasibility and responsiveness to change
  14. Mitochondrial DNA haplogroups and age at onset of Machado–Joseph disease/spinocerebellar ataxia type 3: a study in patients from multiple populations
  15. Correction to: Selective Forces Related to Spinocerebellar Ataxia Type 2
  16. Genetic risk factors for modulation of age at onset in Machado-Joseph disease/spinocerebellar ataxia type 3: a systematic review and meta-analysis
  17. Cross-cultural adaptation and validation of the International Cooperative Ataxia Rating Scale (ICARS) to Brazilian Portuguese
  18. Age at onset prediction in spinocerebellar ataxia type 3 changes according to population of origin
  19. Selective Forces Related to Spinocerebellar Ataxia Type 2
  20. Friedreich Ataxia: Diagnostic Yield and Minimal Frequency in South Brazil
  21. The progression rate of spinocerebellar ataxia type 2 changes with stage of disease
  22. Clinical and molecular characterization of hereditary spastic paraplegias: A next-generation sequencing panel approach
  23. Molecular and biochemical biomarkers for diagnosis and therapy monitorization of Niemann‐Pick type C patients
  24. NTRK2 (TrkB gene) variants and temporal lobe epilepsy: A genetic association study
  25. Haplotype Study in SCA10 Families Provides Further Evidence for a Common Ancestral Origin of the Mutation
  26. Neurological phenotypes in spinocerebellar ataxia type 2: Role of mitochondrial polymorphism A10398G and other risk factors
  27. Tyrosine receptor kinase B gene variants (NTRK2 variants) are associated with depressive disorders in temporal lobe epilepsy
  28. Spinocerebellar ataxia type 10: common haplotype and disease progression rate in Peru and Brazil
  29. NESSCA Validation and Responsiveness of Several Rating Scales in Spinocerebellar Ataxia Type 2
  30. Dentatorubro-Pallidoluysian Atrophy (DRPLA) among 700 Families with Ataxia in Brazil
  31. Cancer in Machado–Joseph disease patients—low frequency as a cause of death
  32. Neurological outcomes after hematopoietic stem cell transplantation for cerebral X-linked adrenoleukodystrophy, late onset metachromatic leukodystrophy and Hurler syndrome
  33. Selective screening of Niemann–Pick type C Brazilian patients by cholestane-3β,5α,6β-triol and chitotriosidase measurements followed by filipin staining and NPC1/NPC2 gene analysis
  34. BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
  35. Glycosylation is crucial for a proper catalytic site organization in human glucocerebrosidase
  36. Spinocerebellar ataxia type 3/Machado-Joseph disease: segregation patterns and factors influencing instability of expanded CAG transmissions
  37. Non-motor and Extracerebellar Features in Spinocerebellar Ataxia Type 2
  38. Spinocerebellar ataxia type 3/Machado-Joseph disease starting before adolescence
  39. Nonneurological Involvement in Late-Onset Friedreich Ataxia (LOFA): Exploring the Phenotypes
  40. Pattern of Peripheral Nerve Involvement in Spinocerebellar Ataxia Type 2: a Neurophysiological Assessment
  41. Planning future clinical trials in Machado Joseph disease: Lessons from a phase 2 trial
  42. Cytokines in Machado Joseph Disease/Spinocerebellar Ataxia 3
  43. Genetic aspects of Huntington's disease in Latin America. A systematic review
  44. Genotypic characterization of Brazilian patients with infantile and juvenile forms of metachromatic leukodystrophy
  45. Infantile spinocerebellar ataxia type 7: Case report and a review of the literature
  46. Clinical Scales Predict Significant Videofluoroscopic Dysphagia in Machado Joseph Disease Patients
  47. Broad clinical and laboratory spectrum found in 9 Niemann–Pick disease type C Southern Brazilian patients
  48. Oxysterol measurement in plasma: A potentially useful tool for the screening of Niemann–Pick disease type C disease
  49. Should spinocerebellar ataxias be included in the differential diagnosis for Huntington's diseases-like syndromes?
  50. Identification of miRNAs that modulate glucocerebrosidase activity in Gaucher disease cells
  51. Niemann-Pick disease type C: a case series of Brazilian patients
  52. MiRNAs and glucocerebrosidase: lessons from miRNA mimic screening
  53. Neurological phenotypes in Niemann-Pick disease type C (NPC): clinical, biochemical and neuroradiological retrospective review of 48 Brazilian patients
  54. A randomized, phase 2 clinical trial of lithium carbonate in Machado-Joseph disease
  55. A de novo or germline mutation in a family with Mucolipidosis III gamma: Implications for molecular diagnosis and genetic counseling
  56. Huntington disease and Huntington disease-like in a case series from Brazil
  57. Unusual movement disorders in spinocerebellar ataxias
  58. Spinocerebellar Ataxias in Brazil—Frequencies and Modulating Effects of Related Genes
  59. Screening of high-risk Gaucher disease patients using dried blood spots techniques
  60. Nonmotor and extracerebellar features in Machado-Joseph disease: A review
  61. Genetic Diagnosis in Recently Transfused Patients
  62. Effects of glycosylation and pH conditions in the dynamics of human arylsulfatase A
  63. Diagnostic contribution of molecular analysis of the cystic fibrosis transmembrane conductance regulator gene in patients suspected of having mild or atypical cystic fibrosis
  64. A comprehensive program for the diagnosis of Niemann–Pick disease type C in Brazil (NPC Brazil Network)
  65. Prevalence of ERα-397 PvuII C/T, ERα-351 XbaI A/G and PGR PROGINS polymorphisms in Brazilian breast cancer-unaffected women
  66. High twinning rate in Candido Godoi: a new role for p53 in human fertility
  67. GSTM1, GSTT1, and GSTP1 polymorphisms, breast cancer risk factors and mammographic density in women submitted to breast cancer screening
  68. Sequence Analysis of 5′ Regulatory Regions of the Machado–Joseph Disease Gene (ATXN3)
  69. Glucocerebrosidase gene variants in parkinsonian patients with Machado Joseph/spinocerebellar ataxia 3
  70. Erratum to: Body Mass Index is Inversely Correlated with the Expanded CAG Repeat Length in SCA3/MJD Patients
  71. Alterations of PI3K and Akt signaling pathways in the hippocampus and hypothalamus of Wistar rats treated with highly palatable food
  72. Normal ATXN3 Allele but Not CHIP Polymorphisms Modulates Age at Onset in Machado–Joseph Disease
  73. Novel Mutations in the Glucocerebrosidase Gene of Brazilian Patients with Gaucher Disease
  74. A patient presenting a 22q13 deletion associated with an apparently balanced translocation t(16;22): an illustrative case in the investigation of patients with low ARSA activity
  75. Molecular Analysis of Spinal Muscular Atrophy: a genotyping protocol based on TaqMan® real-time PCR
  76. The <emph type="ital">APOE</emph> ε2 Allele Increases the Risk of Earlier Age at Onset in Machado-Joseph Disease
  77. Body Mass Index is Inversely Correlated with the Expanded CAG Repeat Length in SCA3/MJD Patients
  78. Akathisia: An unusual movement disorder in Machado–Joseph disease
  79. Presymptomatic Testing for Neurogenetic Diseases in Brazil: Assessing Who Seeks and Who Follows through with Testing
  80. Tetrahydrobiopterin responsiveness of patients with phenylalanine hydroxylase deficiency
  81. Prevalence of the STK15 F31I polymorphism and its relationship with mammographic density
  82. Optimized loading test to evaluate responsiveness to tetrahydrobiopterin (BH4) in Brazilian patients with phenylalanine hydroxylase deficiency
  83. Prevalence ofUGT1A1Gene Polymorphism in Patients with Hemolytic Anemia in Southern Brazil
  84. Does DNA methylation in the promoter region of the ATXN3 gene modify age at onset in MJD (SCA3) patients?
  85. Serum insulin-like system alterations in patients with spinocerebellar ataxia type 3
  86. Depressive Mood is Associated with Ataxic and Non-Ataxic Neurological Dysfunction in SCA3 Patients
  87. Clinical and biochemical study of 29 Brazilian patients with metachromatic leukodystrophy
  88. EMQN Best Practice Guidelines for molecular genetic testing of SCAs
  89. No major clinical impact of Val66Met BDNF gene polymorphism on temporal lobe epilepsy
  90. Polymorphic Variants of UGT1A1 in Neonatal Jaundice in Southern Brazil
  91. Clinical and histomolecular endometrial tumor characterization of patients at-risk for Lynch syndrome in South of Brazil
  92. Common origin of pure and interrupted repeat expansions in spinocerebellar ataxia type 2 (SCA2)
  93. Brain-derived neurotrophic factor gene val66met polymorphism and executive functioning in patients with bipolar disorder
  94. Intrafamilial variability of Parkinson phenotype in SCAs: Novel cases due to SCA2 and SCA3 expansions
  95. Ancestral Origin of the ATTCT Repeat Expansion in Spinocerebellar Ataxia Type 10 (SCA10)
  96. Parkinson's disease and the heterozygous state for glucocerebrosidase mutations among Brazilians
  97. In vitro correction of ARSA deficiency in human skin fibroblasts from Metachromatic Leukodystrophy patients after treatment with microencapsulated recombinant cells
  98. Pathogenic expansions of the SCA6 locus are associated with a common CACNA1A haplotype across the globe: founder effect or predisposing chromosome?
  99. Prevalence of 4977bp Deletion in Mitochondrial DNA from Patients with Chronic Kidney Disease Receiving Conservative Treatment or Hemodialysis in Southern Brazil
  100. Machado-Joseph Disease Enhances Genetic Fitness: A Comparison Between Affected and Unaffected Women and Between MJD and the General Population
  101. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease
  102. Depressive Symptoms in Machado-Joseph Disease (SCA3) Patients and Their Relatives
  103. Spinocerebellar ataxias in 114 Brazilian families: clinical and molecular findings
  104. Reduced penetrance of intermediate size alleles in spinocerebellar ataxia type 10
  105. Conventional MRI and MR spectroscopy in nonclassical mitochondrial disease: report of three patients with mitochondrial DNA deletion
  106. Biochemical properties of β-glucosidase in leukocytes from patients and obligated heterozygotes for Gaucher disease carriers
  107. Biochemical characterization of chitotriosidase enzyme: comparison between normal individuals and patients with Gaucher and with Niemann–Pick diseases
  108. Impaired P50 sensory gating in Machado-Joseph disease
  109. Molecular characterization of phenylketonuria in South Brazil
  110. Searching for modulating effects of SCA2, SCA6 and DRPLA CAG tracts on the Machado-Joseph disease (SCA3) phenotype
  111. Use of fluoxetine for treatment of Machado-Joseph disease: an open-label study
  112. A survey of spinocerebellar ataxia in South Brazil - 66 new cases with Machado-Joseph disease, SCA7, SCA8, or unidentified disease-causing mutations
  113. Machado-Joseph disease in South Brazil: clinical and molecular characterization of kindreds
  114. Aspartame loading test in PKU heterozygous individuals bearing severe and moderate mutations
  115. A Regulatory Element in Intron 1 of the Cystic Fibrosis Transmembrane Conductance Regulator Gene
  116. A single origin for the most frequent mutation causing late infantile metachromatic leucodystrophy.
  117. The arylsulphatase A gene and molecular genetics of metachromatic leucodystrophy.
  118. Gaucher's disease in the United Kingdom: screening non-Jewish patients for the two common mutations.
  119. Prevalence of common mutations in the arylsulphatase A gene in metachromatic leukodystrophy patients diagnosed in Britain
  120. Application of a flowchart for the detection of lysosomal storage diseases in 105 high-risk Brazilian patients
  121. Inborn Errors of Metabolism